HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
6 hedge funds and large institutions have $15.3M invested in Hepion Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$3.4M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$1.26M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$744K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$416K |
Top Sellers
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
-$4.41M |
| 2 |
Morgan Stanley
New York
|
-$250K |
| 3 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$207K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$32K |
| 5 |
Barclays
London,
United Kingdom
|
-$28K |
